Mechanisms of antimicrobial resistance among hospital-associated pathogens
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 16, Issue 4, Pages 269-287
Publisher
Informa UK Limited
Online
2018-04-05
DOI
10.1080/14787210.2018.1456919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colonization resistance: The deconvolution of a complex trait
- (2017) Erin E. Olsan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?
- (2017) B. Davido et al. JOURNAL OF HOSPITAL INFECTION
- Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins
- (2016) Andrew M. King et al. ACS Chemical Biology
- Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus
- (2016) Adriana Renzoni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
- (2016) Bhavarth S. Shukla et al. CLINICAL INFECTIOUS DISEASES
- Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With RecurrentClostridium difficileInfection After Fecal Microbiota Transplantation
- (2016) Hanne Jouhten et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With RecurrentClostridium difficileInfection
- (2016) Braden Millan et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Cell wall hydrolases and antibiotics: exploiting synergy to create efficacious new antimicrobial treatments
- (2016) Michael Wittekind et al. CURRENT OPINION IN MICROBIOLOGY
- Targeting cell membrane adaptation as a novel antimicrobial strategy
- (2016) Truc T Tran et al. CURRENT OPINION IN MICROBIOLOGY
- Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
- (2016) Ruth Keary et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Prevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings
- (2016) Andie S. Lee et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
- (2016) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dissemination of the mcr-1 colistin resistance gene
- (2016) Yongfei Hu et al. LANCET INFECTIOUS DISEASES
- Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
- (2016) Hong Du et al. LANCET INFECTIOUS DISEASES
- Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany
- (2016) Linda Falgenhauer et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
- (2016) Xu Yao et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
- (2016) Anna Müller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens
- (2016) Eric G. Pamer SCIENCE
- ABC-F Proteins Mediate Antibiotic Resistance through Ribosomal Protection
- (2016) Liam K. R. Sharkey et al. mBio
- Diversified mcr-1 -Harbouring Plasmid Reservoirs Confer Resistance to Colistin in Human Gut Microbiota
- (2016) Huiyan Ye et al. mBio
- β-Lactam Resistance Mechanisms: Gram-Positive Bacteria andMycobacterium tuberculosis
- (2016) Jed F. Fisher et al. Cold Spring Harbor Perspectives in Medicine
- Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
- (2016) Benjamin K. Chan et al. Scientific Reports
- Fecal Microbiota Transplantation forClostridium difficileInfection
- (2015) Dimitri Drekonja et al. ANNALS OF INTERNAL MEDICINE
- Using a Novel Lysin To Help Control Clostridium difficile Infections
- (2015) Qiong Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Deletion ofliaRReverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background
- (2015) Diana Panesso et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteriophage Combinations Significantly Reduce Clostridium difficile GrowthIn Vitroand ProliferationIn Vivo
- (2015) Janet Y. Nale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Phage Lysin Capable of Killing the Multidrug-Resistant Gram-Negative Bacterium Acinetobacter baumannii in a Mouse Bacteremia Model
- (2015) Rolf Lood et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria
- (2015) Abdelhamid Asli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency and Distribution of Single-Nucleotide Polymorphisms withinmprFin Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides
- (2015) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantitative Imaging of Gut Microbiota Spatial Organization
- (2015) Kristen A. Earle et al. Cell Host & Microbe
- Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance
- (2015) James A. Karlowsky et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
- (2015) Jeong Jeon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A novel gene,optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence inEnterococcus faecalisandEnterococcus faeciumof human and animal origin
- (2015) Yang Wang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization ofEscherichia coliNDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
- (2015) Richard A. Alm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection
- (2015) Mathias Schmelcher et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae
- (2015) J.-C. Lagier et al. JOURNAL OF HOSPITAL INFECTION
- No Vacancy: How Beneficial Microbes Cooperate with Immunity To Provide Colonization Resistance to Pathogens
- (2015) Martina Sassone-Corsi et al. JOURNAL OF IMMUNOLOGY
- Pheromone killing of multidrug-resistantEnterococcus faecalisV583 by native commensal strains
- (2015) Michael S. Gilmore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
- (2015) Jennifer A. Johnson et al. Open Forum Infectious Diseases
- PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2014) S. Wesley Long et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
- (2014) Lorena Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
- (2014) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of a P1-Like Bacteriophage Carrying an SHV-2 Extended-Spectrum β-Lactamase from an Escherichia coli Strain
- (2014) Typhaine Billard-Pomares et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment
- (2014) Antonio Cannatelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
- Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease
- (2014) R. Singh et al. CLINICAL MICROBIOLOGY AND INFECTION
- Differential Expression of Two-Component Systems, pmrAB and phoPQ, with Different Growth phases of Klebsiella pneumoniae in the Presence or Absence of Colistin
- (2014) So Yeon Kim et al. CURRENT MICROBIOLOGY
- Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
- (2014) Rodrigo E. Mendes et al. DRUG RESISTANCE UPDATES
- Resistance to rifampicin: a review
- (2014) Beth P Goldstein JOURNAL OF ANTIBIOTICS
- Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
- (2014) R. A. Alm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
- (2014) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanisms of vancomycin resistance in Staphylococcus aureus
- (2014) Susana Gardete et al. JOURNAL OF CLINICAL INVESTIGATION
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- (2014) Thomas P Van Boeckel et al. LANCET INFECTIOUS DISEASES
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
- (2014) Flávia Rossi et al. NEW ENGLAND JOURNAL OF MEDICINE
- AliaFCodon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis
- (2013) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Causal Role of Single Nucleotide Polymorphisms within themprFGene of Staphylococcus aureus in Daptomycin Resistance
- (2013) Soo-Jin Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impaired Virulence and Fitness of a Colistin-Resistant Clinical Isolate of Acinetobacter baumannii in a Rat Model of Pneumonia
- (2013) Sami Hraiech et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin Resistance ofPseudomonas aeruginosa phoQMutants Is Dependent on Additional Two-Component Regulatory Systems
- (2013) Alina D. Gutu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus
- (2013) Daniel B. Gilmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Derepressed Transfer Properties Leading to the Efficient Spread of the Plasmid Encoding Carbapenemase OXA-48
- (2013) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid for the Management of Human Infections: In Vitro Characteristics
- (2013) Jeffrey B. Locke et al. CLINICAL INFECTIOUS DISEASES
- Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011
- (2013) A Potron et al. Eurosurveillance
- Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization
- (2013) Carles Ubeda et al. INFECTION AND IMMUNITY
- Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms
- (2013) Hongbin Chen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus
- (2013) Viviana Cafiso et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals
- (2013) S. Rincon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The ABCD’s of β-lactamase nomenclature
- (2013) Karen Bush JOURNAL OF INFECTION AND CHEMOTHERAPY
- Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia
- (2013) Raymond Schuch et al. JOURNAL OF INFECTIOUS DISEASES
- Ribosome-targeting antibiotics and mechanisms of bacterial resistance
- (2013) Daniel N. Wilson NATURE REVIEWS MICROBIOLOGY
- Structure of an ‘open’ clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport
- (2013) Ivan Laponogov et al. NUCLEIC ACIDS RESEARCH
- Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids
- (2013) T. T. Tran et al. mBio
- Bacterial cell-wall recycling
- (2012) Jarrod W. Johnson et al. Annals of the New York Academy of Sciences
- Combination Therapy with Ampicillin and Daptomycin for Treatment of Enterococcus faecalis Endocarditis
- (2012) M. Sierra-Hoffman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
- (2012) Cory Hafer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transferable Plasmid-Mediated Resistance to Linezolid Due tocfrin a Human Clinical Isolate of Enterococcus faecalis
- (2012) Lorena Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15
- (2012) Flavie Pouillot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs
- (2012) T. Noël JOURNAL DE MYCOLOGIE MEDICALE
- Purification and Activity Testing of the Full-Length YycFGHI Proteins of Staphylococcus aureus
- (2012) Michael Türck et al. PLoS One
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
- (2012) Nagendra N. Mishra et al. PLoS One
- CTX-M Enzymes: Origin and Diffusion
- (2012) Rafael Cantón et al. Frontiers in Microbiology
- Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
- (2011) Michael A. Pfaller AMERICAN JOURNAL OF MEDICINE
- d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
- (2011) François Lebreton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Fitness Cost of the Multidrug Resistance Genecfr
- (2011) Jacqueline M. LaMarre et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Basis for Daptomycin Resistance in Enterococci
- (2011) Kelli L. Palmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- (2011) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
- (2011) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Hospital Epidemiology and Infection Control in Acute-Care Settings
- (2011) E. R. M. Sydnor et al. CLINICAL MICROBIOLOGY REVIEWS
- Bacitracin sensing and resistance in Staphylococcus aureus
- (2011) Yuuma Yoshida et al. FEMS MICROBIOLOGY LETTERS
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Bacteriophage-mediated transduction of antibiotic resistance in enterococci
- (2011) R. Mazaheri Nezhad Fard et al. LETTERS IN APPLIED MICROBIOLOGY
- Antibiotic resistance is ancient
- (2011) Vanessa M. D’Costa et al. NATURE
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus
- (2010) E. C. Nannini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
- (2010) X. Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adaptive Resistance to the "Last Hope" Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS
- (2010) L. Fernandez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a New Cephalosporin, CXA-101 (FR264205), against -Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Linezolid Is Mediated by thecfrGene in the First Report of an Outbreak of Linezolid‐ResistantStaphylococcus aureus
- (2010) Gracia Morales et al. CLINICAL INFECTIOUS DISEASES
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Candida Infections of the Genitourinary Tract
- (2010) J. M. Achkar et al. CLINICAL MICROBIOLOGY REVIEWS
- Aminoglycoside modifying enzymes
- (2010) Maria S. Ramirez et al. DRUG RESISTANCE UPDATES
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
- (2010) Alexandre Wohlkonig et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure
- (2009) E. C. Nannini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alterations in Two-Component Regulatory Systems of phoPQ and pmrAB Are Associated with Polymyxin B Resistance in Clinical Isolates of Pseudomonas aeruginosa
- (2009) K. Barrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
- (2009) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antifungal Drug Resistance
- (2009) R. D. Cannon et al. CLINICAL MICROBIOLOGY REVIEWS
- Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)
- (2009) B. A. Cunha et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of Class A Penicillin-Binding Proteins in the Expression of -Lactam Resistance in Enterococcus faecium
- (2009) L. B. Rice et al. JOURNAL OF BACTERIOLOGY
- Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
- (2009) Frank R. DeLeo et al. JOURNAL OF CLINICAL INVESTIGATION
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin
- (2008) L. M. Cavaco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL
- (2008) D. A. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
- (2008) N. Cotroneo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
- Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes
- (2008) Marilyn C. Roberts FEMS MICROBIOLOGY LETTERS
- Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
- (2008) M. H. Murthy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
- (2008) E. Llobet et al. MICROBIOLOGY-SGM
- A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway
- (2008) Sarah Dubrac et al. MOLECULAR MICROBIOLOGY
- Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
- (2008) Katharina Brandl et al. NATURE
- The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
- (2008) Jean-Marie Pagès et al. NATURE REVIEWS MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now